Publicaciones en las que colabora con Juan Antonio García Velasco (52)

2022

  1. Avoid mixing apples and oranges: blastocysts diagnosed with uniform whole chromosome aneuploidies are reproductively incompetent and their transfer is harmful

    Human reproduction (Oxford, England)

2018

  1. Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients

    Fertility and Sterility, Vol. 109, Núm. 6, pp. 968-979

2015

  1. Is endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study

    Reproductive BioMedicine Online, Vol. 31, Núm. 5, pp. 647-654

2014

  1. Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression

    Fertility and Sterility, Vol. 101, Núm. 1

  2. The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity

    Human Reproduction, Vol. 29, Núm. 6, pp. 1271-1278

2012

  1. Follicular and endocrine profiles associated with different GnRH-antagonist regimens: A randomized controlled trial

    Reproductive BioMedicine Online, Vol. 24, Núm. 2, pp. 153-162

2011

  1. High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist

    Reproductive BioMedicine Online, Vol. 22, Núm. S1, pp. S52-S59

  2. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis

    Reproduction, Vol. 142, Núm. 5, pp. 745-755

2010

  1. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: A novel molecular target for endometriosis therapy

    Biology of Reproduction, Vol. 83, Núm. 5, pp. 866-873

  2. Physiology and pathology of ovarian hyperstimulation syndrome

    Seminars in Reproductive Medicine, Vol. 28, Núm. 6, pp. 448-457

  3. Prevención del síndrome de hiperestimulación ovárica

    Revista Iberoamericana de Fertilidad y Reproduccion Humana

  4. Prevention of OHSS: Current strategies and new insights

    Middle East Fertility Society Journal, Vol. 15, Núm. 4, pp. 223-230

  5. The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: A randomized, double-blind, placebo-controlled trial

    Human Reproduction, Vol. 25, Núm. 4, pp. 995-1004

2009

  1. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

    Obstetrical and Gynecological Survey

  2. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

    Human Reproduction, Vol. 24, Núm. 5, pp. 1025-1035

  3. Symposium: Update on prediction and management of OHSS: Prevention of OHSS - Dopamine agonists

    Reproductive BioMedicine Online

2008

  1. Clinical factors affecting endometrial receptiveness in oocyte donation cycles

    Fertility and Sterility, Vol. 89, Núm. 3, pp. 491-501

  2. Dysfunctional uterine bleeding

    Non-Invasive Management of Gynecologic Disorders (CRC Press), pp. 63-68

  3. Molecular mechanisms of implantation

    Infertility and Assisted Reproduction (Cambridge University Press), pp. 46-52

  4. Ovarian hyperstimulation syndrome

    Infertility and Assisted Reproduction (Cambridge University Press), pp. 243-257